Hims & Hers appoints first-ever Chief Pharmacy & Innovation Officer
05 Dezember 2022 - 03:00PM
Business Wire
Dr. Scott Knoer was previously Chief Pharmacy
Officer at Cleveland Clinic & CEO of the American Pharmacists
Association
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS),
the trusted consumer-first platform focused on providing modern
personalized health and wellness experiences to consumers, today
made a key leadership appointment, naming pharmacy industry veteran
Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever
Chief Pharmacy & Innovation Officer.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20221205005225/en/
Dr. Scott Knoer, Chief Pharmacy &
Innovation Officer at Hims & Hers (Photo: Business Wire)
In this role, Dr. Knoer will oversee pharmacy strategy and
innovation efforts for Hims & Hers. Knoer will direct efforts
to develop proprietary formulations that will make it possible to
provide customers with personalized health and wellness
advancements. Hims & Hers recent pharmacy developments include
a 300,000 square foot facility in Ohio and a recently opened 25,000
square foot facility in Arizona.
“Modern healthcare requires a pioneering approach to improve the
solutions of today and deliver the advancements of tomorrow. The
addition of Dr. Knoer as Chief Pharmacy & Innovation Officer is
the next step forward for our brand, our team and our solutions,”
said Andrew Dudum, Chief Executive Officer at Hims & Hers.
“Scott is a deep bench academic with real-world experience
transforming pharmacy operations at a large health network, and a
proven leader in the field. His impact will be immediate as we
develop more personalized solutions for everyone,” added Dudum.
“I am humbled by this opportunity to help define the future of
modern healthcare and wellness,” said Dr. Scott Knoer, Chief
Pharmacy & Innovation Officer at Hims & Hers. “I’ve spent
my career at the cutting edge of pharmacy innovation, and I am
incredibly excited to put that skillset to work. The level of
innovation and personalization being done across Hims & Hers
pharmacy operations is truly disruptive and unlike anything I have
seen before. The true power and impact of compounded pharmacy
solutions is just beginning, and it's clear that Hims & Hers
has a crystal clear vision to define the next stage of this
industry,” added Knoer.
Dr. Knoer brings over two decades of executive and academic
experience at the highest levels of the pharmacy industry. Prior to
joining Hims & Hers, he was the Executive Vice President and
CEO of the American Pharmacists Association (APhA) – the
62,000-member professional organization that supports pharmacists
in all practice settings across the United States, and helps to
develop national guidelines, policies, and best practices that
promote patient care and the pharmacist profession.
Prior to leading APhA, Dr. Knoer spent nearly a decade as Chief
Pharmacy Officer at the Cleveland Clinic. In this role, he was
responsible for all of the Cleveland Clinic’s pharmacy operations,
which included the clinic and cancer center; facilities in Ohio,
Florida, Toronto, Ontario, Abu Dhabi, and London; 1,500 full-time
employees; and an annual $1.4 billion drug budget.
Dr. Knoer has also held pharmacy leadership roles at the
University of Minnesota Medical Center - Fairview, and the
University of Texas Medical Branch at Galveston. He earned his
Doctor of Pharmacy degree at the University of Nebraska College of
Pharmacy and completed a residency and master’s degree in Hospital
Pharmacy at the University of Kansas Medical Center. Dr. Knoer also
brings vast experience across academia, lecturing at dozens of
colleges of pharmacy and holding academic appointments at Northeast
Ohio Medical University, the University of Texas College of
Pharmacy, and the University of Minnesota College of Pharmacy. Dr.
Knoer has over 50 peer reviewed publications and has delivered
hundreds of national and international invited and keynote
lectures. He is an internationally recognized pharmacy expert who
has been quoted over 100 times in major national media outlets
including print, radio, podcasts and television.
Today’s announcement comes on the heels of one of the company’s
strongest quarterly earnings reports to date. In Q3 2022, the
company reported a record 170,000 new subscriptions, bringing total
subscriptions to 991,000. Revenue was up 95% year-over-year to
$144.8 million – the third straight quarter of over $100 million in
revenue. To see the full Q3 2022 results, click here.
About Hims & Hers
Hims & Hers is a consumer-first platform transforming the
way customers fulfill their health and wellness needs. Its digital
platform enables access to treatments for a broad range of
conditions, including those related to sexual health, hair loss,
dermatology, mental health and primary care. Hims & Hers
connects patients to licensed healthcare professionals who can
prescribe medications when appropriate. Prescriptions are fulfilled
online through licensed pharmacies on a subscription basis, making
accessing treatments simple, affordable, and straightforward.
Through the Hims & Hers mobile apps, consumers can access a
range of educational programs, wellness content, community support,
and other services that promote lifelong health and wellness. Hims
& Hers products can also be found in tens of thousands of top
retail locations in the United States. Launched in November 2017,
Hims & Hers serves the entire United States and select
locations in the United Kingdom. The company is publicly traded on
the New York Stock Exchange. For more information about Hims &
Hers, please visit forhims.com and forhers.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221205005225/en/
Investor Relations investors@forhims.com
Media Relations press@forhims.com
Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Mär 2023 bis Mär 2024